JAYDESS Drug Utilization Study in Sweden

Pharmacoepidemiological Study (Drug Utilization Study) of JAYDESS Use in Routine Clinical Practice in Sweden

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT02349815

Enrollment

10000

Registered

2015-01-29

Start date

2017-01-01

Completion date

2022-04-01

Last updated

2023-01-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Contraception

Keywords

Drug Utilization Study

Brief summary

* To describe characteristics (demographic, clinical, social) of first time users of Jaydess * To estimate the duration of use of Jaydess * To study switching patterns, e.g. what are the hormonal contraceptive methods used before and what are the methods after discontinuing Jaydess * To study off-label use of Jaydess

Interventions

DRUGLevonorgestrel (Jaydess, Skyla, BAY86-5028)

Women use Levonorgestrel (Jaydess, BAY86-5028) .

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

18 Years to 64 Years

Healthy volunteers

Inclusion criteria

* Swedish women who were dispensed a JAYDESS from a Swedish Pharmacy anytime 2014-2017

Exclusion criteria

Design outcomes

Primary

Measure	Time frame
Duration of use of JAYDESS	Up to 6 years
Indication for use	At insertion

Secondary

Measure	Time frame
Age at insertion and removal	Up to 6 years

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026